Suppression of tumorigenicity and metastasis in B16F10 cells by PTEN/MMAC1/TEP1 gene

Cancer Letters

Volumn 172, Issue 1, 2001, Pages 83-91

  Hwang, Pyoung Han ^a   Yi, Ho keun ^a   Kim, Dal Sik ^b   Nam, Sang Yun ^c   Kim, Jung Soo ^a   Lee, Dae Yeol ^a  

^a Chonbuk National University Medical School   (South Korea)

^b Chonbuk National University   (South Korea)

^c Jeonju University   (South Korea)

Author keywords

B16F10 cells; Metastasis; PTEN MMAC1 TEP1; Tumorigenicity

Indexed keywords

MATRIX METALLOPROTEINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; SOMATOMEDIN; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; MELANOMA; MELANOMA CELL; METASTASIS; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL DIVISION; DNA, COMPLEMENTARY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOTHELIAL GROWTH FACTORS; FEMALE; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; LYMPHOKINES; MATRIX METALLOPROTEINASES; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MUTATION; NEOPLASM METASTASIS; PHOSPHORIC MONOESTER HYDROLASES; PTEN PHOSPHOHYDROLASE; RADIOIMMUNOASSAY; TIME FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

ANIMALIA;

EID: 0035935261     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(01)00632-2     Document Type: Article

References (29)

1. Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers
2. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta
3. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines
4. Functional and molecular analyses of 10q deletions in human gliomas
5. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome
6. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-triphosphate
7. PTEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase
8. Phosphatases and tumorigenesis
9. From form to function: Signaling by protein tyrosine phosphatases
10. Akt signaling: Linking membrane events to life and death decisions
11. Genetic alterations of the tumor suppressor gene PTEN/MMAC1 in human brain metastases
12. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN
13. Bcl-xs gene therapy induce apoptosis of human mammary tumors in nude mice
14. Matrix metalloproteinases molecular aspects of their roles in tumour invasion and metastasis
15. Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain
16. Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: Differential involvement of focal adhesion kinase and p130Cas
17. Antiapoptotic signaling in LNCaP prostate cancer cells: A survival signaling pathway independent of phosphatidylinositol 3′-kinase and Akt/protein kinase B
18. Chromosomal imbalance maps of malignant solid tumors: A cytogenetic survey of 3185 neoplasms
19. Somatic mutations of PTEN in glioblastoma multiforme
20. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies
21. PTEN is frequently mutated in primary endometrial carcinomas
22. PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphatidylinositol 3-kinase/Akt cell survival pathway
23. Autocrine and paracrine regulation by cytokines and growth factors in melanoma
24. In vitro loss of heterozygosity targets th PTEN/MMAC1 gene in melanoma
25. Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer
26. Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN
27. WAF1, a potential mediator of p53 tumor suppression
28. Wild-type p53 induces apoptosis of myeloid leukemia cells that is inhibited by interleukin-6
29. Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells